Relapse

Long-acting injectable antipsychotics benefit certain patients and should be included in the treatment of schizophrenia, according to a presenter at the NEI Max virtual conference.

A “high relative abundance” of a gut microbiota species in the Blautia genus correlated with a greater risk for MS relapse in pediatric patients, according to findings presented during an encore session of MSVirtual2020.

Women with relapsing-remitting MS who had higher levels of disease activity and were managed on moderate- or high-efficacy therapy were at greater risk for relapse during pregnancy, researchers reported.

The FDA has approved Kesimpta, the first self-administered, targeted B-cell therapy for patients with relapsing multiple sclerosis, the manufacturer announced.

Among patients with multiple sclerosis, ofatumumab was associated with lower annualized relapse rates than teriflunomide, according to a pair of phase 3 randomized controlled trials published in The New England Journal of Medicine.

Studies presented during the ASCO2020 Virtual Scientific Program showed the benefit of validated selection tools in pursuing surgical measures for ovarian cancer relapse, Ursula A. Matulonis, MD, of Dana Farber Cancer Institute, told Healio.

Women with severe or recurrent depression were more likely to relapse during pregnancy after antidepressant discontinuation, according to results of a systematic review and meta-analysis published in Journal of Clinical Psychiatry.

Following antidepressant discontinuation, patient decisions related to “effortful behavior” were associated with prospective relapse risk, according to a study conducted in Switzerland and Germany and published in JAMA Psychiatry.

Computational markers have revealed that patients in treatment for opioid addiction are more likely to relapse when they develop greater tolerance to risks, according to results published in JAMA Psychiatry.